GlassScriptPhysician profile
Ali Hamad Haidar
NPI 1104892058
$2,130.95
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,327 · 2020: $110 · 2021: $152 · 2022: $269 · 2023: $206 · 2024: $66.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $854.41 | 2019 | |
| Glaxosmithkline, LLC. | $567.42 | 2019-2024 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $126.27 | 2019-2022 | |
| Genzyme Corporation | $104.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $80.20 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $73.09 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.61 | 2019 | |
| Genentech USA, INC. | $50.33 | 2019 | |
| Mylan Specialty L.P. | $36.00 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $34.53 | 2019 | |
| Jazz Pharmaceuticals INC. | $22.72 | 2024 | |
| Insmed, INC. | $18.16 | 2020 | |
| United Therapeutics Corporation | $18.16 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.81 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.01 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $14.85 | 2020 | |
| Shire North American Group INC | $14.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.99 | 2021 | |
| Philips North America LLC | $11.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Haidar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.